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Abstract
Introduction: We studied the diagnostic accuracy of bedside lung ultrasound (the presence of a comet-tail sign),
N-terminal pro-brain natriuretic peptide (NT-proBNP) and clinical assessment (according to the modified Boston
criteria) in differentiating heart failure (HF)-related acute dyspnea from pulmonary (chronic obstructive pulmonary
disease (COPD)/asthma)-related acute dyspnea in the prehospital setting.
Methods: Our prospective study was performed at the Center for Emergency Medicine, Maribor, Slovenia, between
July 2007 and April 2010. Two groups of patients were compared: a HF-related acute dyspnea group (n = 129) and
a pulmonary (asthma/COPD)-related acute dyspnea group (n = 89). All patients underwent lung ultrasound
examinations, along with basic laboratory testing, rapid NT-proBNP testing and chest X-rays.
Results: The ultrasound comet-tail sign has 100% sensitivity, 95% specificity, 100% negative predictive value (NPV)
and 96% positive predictive value (PPV) for the diagnosis of HF. NT-proBNP (cutoff point 1,000 pg/mL) has 92%
sensitivity, 89% specificity, 86% NPV and 90% PPV. The Boston modified criteria have 85% sensitivity, 86% specificity,
80% NPV and 90% PPV. In comparing the three methods, we found significant differences between ultrasound sign
and (1) NT-proBNP (P < 0.05) and (2) Boston modified criteria (P < 0.05). The combination of ultrasound sign and
NT-proBNP has 100% sensitivity, 100% specificity, 100% NPV and 100% PPV. With the use of ultrasound, we can
exclude HF in patients with pulmonary-related dyspnea who have positive NT-proBNP (> 1,000 pg/mL) and a
history of HF.
Conclusions: An ultrasound comet-tail sign alone or in combination with NT-proBNP has high diagnostic accuracy
in differentiating acute HF-related from COPD/asthma-related causes of acute dyspnea in the prehospital
emergency setting.
Trial registration: ClinicalTrials.gov NCT01235182.
* Correspondence: grmec-mis@siol.net
1Center for Emergency Medicine, Ulica talcev 9, 2000 Maribor, Slovenia
Full list of author information is available at the end of the article
Prosen et al. Critical Care 2011, 15:R114
http://ccforum.com/content/15/2/R114
© 2011 Prosen et al.; licensee BioMed Central Ltd This is an open access article distributed under the terms of the Creative Commons
Attribution License http://creativecommons.org/licenses/by/2.0, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly citedIntroduction
Acute congestive heart failure (CHF) is one of the
main causes of acute dyspnea encountered in prehospi-
tal emergency settings and is associated with high
morbidity and mortality [1-3]. The early and correct
diagnosis presents a significant clinical challenge and is
of primary importance, as misdiagnosis can result in
deleterious consequences to patients [4-6]. Rapid bed-
side tests, especially brain natriuretic peptide (BNP)
and N-terminal pro-brain natriuretic peptide (NT-
proBNP), help in determining the cause of acute dys-
pnea in the prehospital setting [2,7]. Point-of-care bed-
side lung ultrasound has also become a useful method
for diagnosing CHF [8]. The technique is based on the
recognition and analysis of sonographic artefacts
caused by the interaction of water-rich structures and
air, called comet tails or B lines. When such artefacts
are widely detected on anterolateral transthoracic lung
scans, diffuse alveolar-interstitial syndrome can be
diagnosed and the exacerbation of chronic obstructive
pulmonary disease (COPD), another important cause
of acute dyspnea, can be ruled out. Lichtenstein et al.
[9] first described comet-tail signs or B lines indicating
interstitial pulmonary edema, and Lichtenstein and
Mezière [10] described a systematic approach to lung
ultrasound. Volpicelli et al. [11] proposed a simplified
ultrasound approach to diagnosing the alveolar-inter-
stitial syndrome at bedside. Liteplo et al. [12] com-
bined emergency thoracic ultrasound and NT-proBNP
to differentiate CHF from COPD in the emergency
department.
The aim of our study was to determine the diagnostic
accuracy of bedside lung ultrasound (bilateral comet-tail
sign or multiple vertical B lines, referred to as “lung
rockets”), NT-proBNP and clinical assessment in differ-
entiating heart failure (HF)-related acute dyspnea from
pulmonary (COPD/asthma)-related acute dyspnea in the
prehospital setting (that is, in the field).
Materials and methods
This prospective cohort study was performed in the pre-
hospital emergency setting (Center for Emergency Medi-
cine, Maribor, Slovenia) between July 2007 and April
2010. The study was approved by the Ethical Review
Board of the Ministry of Health of Slovenia. During the
period of the study, 248 consecutive patients with acute
dyspnea were treated by emergency teams (emergency
physician, registered nurse and medical technician/driver
in an ambulance or at the prehospital emergency medi-
cal center). After prehospital care, all patients were
admitted (for clinical reasons and/or because they fit the
study design criteria) to the University Clinical Center
Maribor and followed until discharge.
The inclusion criterion for the study was shortness of
breath as the primary complaint (defined as either the
sudden onset of dyspnea without history of chronic dys-
pnea or an increase in the severity of chronic dyspnea).
Exclusion criteria were age < 18 years, history of renal
insufficiency, trauma, severe coronary ischemia (unless
patient’s predominant presentation was dyspnea) and
other causes of dyspnea, comprising pneumonia, pul-
monary embolism, carcinoma, pneumothorax, pleural
effusion, intoxication (drugs), anaphylactic reactions,
upper airway obstruction, bronchial stenosis and gastro-
esophageal reflux disorder, according to the history,
clinical status and additional laboratory tests available in
the prehospital setting (D-dimer, troponin, C-reactive
protein). Among 248 patients, 218 met the criteria for
inclusion in the study. The distribution of all patients is
shown in Figure 1.
After enrollment, patients’ demographic characteris-
tics, symptoms and signs, medical histories, medication
use, chest X-rays and standard blood test results (after
admission to the hospital) were recorded. Our protocol
for clinical assessment of HF-related acute dyspnea (the
prehospital clinical assessment of HF) was designed
according to the Boston criteria [6] and the Framingham
criteria [13] for HF and was explained in our previous
study [2] (Table 1). For additional evaluation of patients
with suspected obstructive causes of dyspnea, we
included criteria for clinical assessment of severe asthma
[14,15] and COPD exacerbation [16] with the value of
modified Boston criteria for HF being ≤ 5.
The final hospital diagnosis of HF-related acute dys-
pnea and pulmonary-related acute dyspnea (the hospital
reference standard for HF and pulmonary diseases:
asthma/COPD) was confirmed by cardiologists and/or
intensive care physicians in the University Clinical Cen-
ter Maribor using the reference standard definition for
HF and pulmonary diseases in accordance with the pre-
viously cited instruments, including chest X-ray, echo-
cardiographic examination, cardiac functional
assessment (exercise test), pulmonary function test,
complete blood count, biochemistry and invasive investi-
gation or angiography [6,13-16].
According to these criteria, identification of indepen-
dent predictors for final diagnosis of acute dyspnea was
performed by examination of 27 variables (Table 2).
Central venous pressure (CVP) in the field was assessed
by the visualization of the external jugular vein, which
correlates well with catheter-measured CVP [17].
During initial evaluation (before application of medi-
cines), a 5-mL sample of blood was collected into a tube
containing edetate calcium disodium for blinded mea-
surement of NT-proBNP. The level of NT-proBNP was
measured using a portable Cardiac Reader device
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Page 2 of 9(Roche Diagnostics, Mannheim, Germany) and recorded
according to the special protocol. The test was finished
within 15 minutes [2,18].
The bedside thoracic ultrasound was performed
according to the protocol described by Cardinale et al.
[8], Volpicelli et al. [11] and Liteplo et al. [12], in which
eight zones of the lungs were scanned (two anterior and
two lateral zones on each side of thorax). We used a
portable ultrasound machine manufactured by SonoSite
(SonoSite, Inc., Bothell, WA, USA). The 10 emergency
physicians were included in the investigations, and they
had to identify the presence or absence of three or more
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total number of patients 
with acute dyspnea 
in prehospital setting 
n = 248 
INCLUSION CRITERIA 
FOR THE STUDY 
  Yes 
No  n = 30 
EXCLUDED FROM 
THE STUDY 
n = 218 
Heart failure- related 
acute dyspnea 
(final hospital diagnosis) 
Pulmonary- related       
acute dyspnea 
(final hospital diagnosis) 
n = 129  n = 89 
ABNORMAL RESULT 
Ultrasound sign YES /  
NT-proBNP >1000 pg/ml /   
prehospital Boston modified 
criteria  ≥ 8 
n= 129 / 116 / 106   n= 0 / 13 / 23  n= 5 / 11 / 14  n= 84 / 78 / 74 
NORMAL RESULT 
Ultrasound sign NO /  
NT-proBNP <1000 pg/ml /   
prehospital Boston modified 
criteria  ≤ 7 
ABNORMAL RESULT 
Ultrasound sign YES /  
NT-proBNP >1000 pg/ml /   
prehospital Boston modified 
criteria  ≥ 8 
NORMAL RESULT 
Ultrasound sign NO /  
NT-proBNP <1000 pg/ml /   
prehospital Boston modified 
criteria  ≤ 7 
Figure 1 Flow diagram illustrating recruitment, exclusion and subsequent grouping of all patients in the study. NT-proBNP, N-terminal
pro-brain natriuretic peptide.
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signs) are hyperechoic reverberation artefacts that origi-
nate at the pleural line and extend vertically to the bot-
tom of the screen. A positive ultrasound examination
according to the definition of Cardinale et al. [8] and
Volpicelli et al. [11] requires two or more positive zones
bilaterally of eight zones measured. All emergency phy-
sicians who participated in our study had attended the
World Interactive Network Focused on Critical Ultra-
Sound provider course. The length of the examination
was always under 1 minute.
NT-proBNP measurements and ultrasound examina-
tions were performed immediately after the arrival of
the patient at the emergency department but before
application of medication, thus our results were not
altered by treatment. The raters who made the diagnosis
(prehospital emergency physicians in the prehospital set-
ting, internists at admission to the hospital and cardiolo-
gists and/or intensive care physicians at discharge from
the hospital with the final diagnosis) were blinded to the
results of NT-proBNP. In addition, the investigators of
NT-proBNP did not collaborate in making the final
diagnosis. On the other side, prehospital emergency
physicians were not blinded to the ultrasound findings,
because bedside lung ultrasound represents the routine
method for assessment of acute dyspnea in our prehos-
pital emergency unit. To avoid bias, the ultrasound find-
ings were recorded by the emergency physicians but did
not affect the diagnosis. The raters who made the diag-
nosis in the hospital were blinded to the findings of pre-
hospital ultrasound. To our knowledge, no previous
study has compared the diagnostic utility of ultrasound
examination and NT-proBNP in a prehospital setting.
Statistical analysis
Univariate comparisons were made by using the c
2 test
for categorical variables and an unpaired t-test for con-
tinuous variables with normal distribution (age, pulse
rate, partial pressure of end-tidal carbon dioxide, NT-
proBNP, arterial oxygen saturation and modified Boston
criteria for HF). Odds ratios (ORs) and 95% confidence
interval (CIs) were calculated to examine the risk of
acute HF (adjusted using multiple logistic regression).
Sensitivity, specificity, negative predictive value (NPV),
positive predictive value (PPV), positive likelihood ratio
(LR
+) and negative likelihood ratio (LR
-) were estimated
for clinical assessment (based on the modified Boston
criteria), NT-proBNP, ultrasound examination and a
combination of ultrasound with NT-proBNP. The com-
parison of these four methods was done by using the c
2
test with the Bonferroni correction for multiple compar-
isons. The area under the receiver-operating curve
(AUROC) was also used to determine the diagnostic
accuracy of the four methods in differentiating HF-
related acute dyspnea from pulmonary-related acute
dyspnea. Single areas were calculated and compared
Table 1 Study protocol for prehospital clinical assessment of HF (modified Boston criteria)
a
Criterion Point value
b
Category I: History Rest dyspnea 4
Orthopnea 4
Paroxysmal nocturnal dyspnea 3
Dyspnea while walking on level area 2
Dyspnea while climbing 1
Category II: Physical examination Heart rate abnormality (1 point if 91 to 110 beats/minute;
2 points if more than 110 beats/minute)
1o r2
Jugular venous elevation (2 points if greater than 5 cmH2O;
3 points if greater than 5 cmH2O plus hepatomegaly or edema)
2o r3
Lung rales (1 point if basilar; 2 points if more than basilar) 1 or 2
Wheezing 3
Third heart sound 3
Category III: Additional
minor criteria
Hepatojugular reflux 1
ECG changes (HLV, old AMI or nonspecific ST-T changes, arrhythmia) 1
Night cough 1
Murmur 1
Without sputum and/or fever 1
Previous AMI, arrhythmia or HF 1
HF medications 1
aBoston criteria [6]. HF, heart failure; ECG, electrocardiogram; HLV, hypertrophy of the left ventricle; AMI, acute myocardial infarction.
bPoint value: no more than 4
points allowed from each of three categories; hence the composite score (sum of the subtotal from each category) has a possible maximum of 12 points. The
diagnosis of heart failure is classified as “definite” at a score 8 to 12 points, “possible” at a score 5 to 7 points and “unlikely” at a score of 4 points or less.
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under different curves using the technique proposed by
Hanley and McNeil [19] and Jannuzzi et al. [20]. Statis-
tical analyses were performed using SPSS software
(SPSS Inc., Chicago, IL, USA). AUROC analysis was per-
formed using Analyze-It software (Leeds, UK).
Consent
The authors confirm that all patients gave their consent
for study participation and potential publication of the
study results.
Results
During the period of the study, 248 consecutive patients
with acute dyspnea were treated by emergency teams
(129 patients with HF-related acute dyspnea and 89
patients with pulmonary-related acute dyspnea). Thirty
patients were excluded from the study. The clinical and
demographic characteristics of patients are presented in
Table 2. The group of patients with acute HF was signif-
icantly older (mean ages 70.9 ± 11.7 years versus 52.3 ±
15.3 years; P = 0.001). The feasibility of ultrasound
examination in the prehospital setting was 100%, and
the duration of the examination was always less than 1
minute. For the identification of independent predictors
for the final diagnosis of acute dyspnea, we examined 24
variables (variables with P < 0.05 on the basis of univari-
ate analysis) in multivariate logistic regression analysis.
Ten variables remained significant after analysis (Table
3 ) .E v i d e n t l y ,t h e r ei sb i gd i f f e r e n c ei nO R sb e t w e e n
ultrasound examinations (mean OR, 53.7; 95% CI, 28.6
to 83.5) and NT-proBNP (mean OR, 14.3; 95% CI, 8.1
to 29.4) and other variables. The ultrasound examina-
tion was the strongest predictor of acute HF.
Table 2 Univariate analysis for all demographic and clinical variables pertinent to diagnosis of acute HF or pulmonary
disease (N = 218)
a
Variables
b Pulmonary-related dyspnea
(n = 89)
Acute HF-related dyspnea
(n = 129)
P value
c
Mean age, yr (± SD) 52.3 ± 15.3 70.9 ± 11.7 0.001
Sex, males/females (%) 176/87 (67%) 1,158/421 (73%) 0.74
Nocturnal dyspnea, Y/N 6/83 1/2 < 0.001
Orthopnea, Y/N 7/82 13/30 < 0.001
Cough, Y/N 17/41 34/95 < 0.001
Sputum production, Y/N 24/65 8/121 < 0.001
Fever, Y/N 21/68 7/122 < 0.001
Murmur, Y/N 8/81 29/100 < 0.001
Rales, Y/N 10/79 217/53 < 0.001
Wheezes, Y/N 12/3 47/82 < 0.001
Mean pulse rate, beats/min (± SD) 115.7 ± 14.1 106.3 ± 12.8 0.564
Jugular venous distension, Y/N 3/86 10/33 < 0.001
Lower extremity edema, Y/N 12/77 62/67 < 0.001
ECG-normal sinus rhythm, Y/N 210/17 55/72 < 0.001
Asthma/COPD medications, Y/N 65/11 13/116 < 0.001
HF medications, Y/N 33/56 245/46 < 0.001
Troponin T > 0.03 ng/mL, Y/N 8/81 49/80 < 0.001
Mean petCO2, kPa (± SD) 6.9 ± 1.6 3.6 ± 1.1 0.01
Mean NT-proBNP, pg/mL (± SD) 598.2 ± 361.8 2,263 ± 641.2 0.008
Mean SaO2, % (± SD) 75.7 ± 10.1 67.9 ± 12.8 0.76
Ultrasound examination-positive, Y/N 5/84 129/0 < 0.001
Previous arrhythmia, Y/N 7/82 52/77 < 0.001
Previous AMI, Y/N 7/82 15/28 < 0.001
Previous CHF, Y/N 17/72 233/49 < 0.001
Previous asthma/COPD, Y/N 169/19 9/34 < 0.001
ETI, Y/N 3/86 10/119 < 0.001
Mean modified Boston criteria score for diagnosing HF
d (± SD) 4.6 ± 1.2 10.9 ± 1.8 < 0.001
aY, yes; N, no; petCO2, partial pressure of end-tidal carbon dioxide; NT-proBNP, amino terminal pro-brain natriuretic peptide; ECG, electrocardiogram; HF, heart
failure; CHF, congestive heart failure; AMI, acute myocardial infarction; SaO2, arterial oxygen saturation; ETI, endotracheal intubation; COPD, chronic obstructive
pulmonary disease.
bResults are presented as means ± standard deviation for normally distributed data or ratio or percentage for other variables.
cUnivariate
comparison was made using the c
2 test for categorical variables and a t-test for continuous variables. For evaluation of diagnostic accuracy, patients were
divided into two groups: HF-related acute dyspnea and pulmonary-related acute dyspnea (COPD/asthma).
dModified Boston criteria according to Table 1 and
Remes et al. [6].
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+,
LR
- and AUROC values are presented for ultrasound
examinations (cutoff point: two or more positive zones
bilaterally), modified Boston criteria (cutoff point: total
8 points), NT-proBNP (cutoff point: 1,000 pg/mL)
and a combination of ultrasound examination with NT-
proBNP. In comparing the methods, we found
significant differences between ultrasound signs versus
NT-proBNP (P <0 . 0 5 )a n du l t r a s o u n ds i g n sv e r s u s
modified Boston criteria (P < 0.05). All 11 patients for
whom false-positive results were found using the NT-
proBNP method had values higher than 1,000 pg/mL
(mean, 1,564 ± 651.3; range, 1,200 to 2,750 pg/mL) and
a history of HF. In all of these 11 patients, we confirmed
the absence of comet-tail signs. With ultrasound, we can
exclude HF in pulmonary-related dyspneic patients with
positive NT-proBNP results and a history of HF. All five
patients for whom false-positive results were found
using the ultrasound method had NT-proBNP values
less than 1,000 pg/mL (mean, 541.3 ± 265.1) and a his-
tory of COPD/asthma. With the value of NT-proBNP,
we can exclude HF in ultrasound-positive pulmonary-
related dyspneic patients.
The combination of ultrasound examination and NT-
proBNP was statistically significantly different from the
use of single methods. It had values of 100% sensitivity,
100% specificity, 100% NPV, 100% PPV, LR
+ infinite,
LR
- zero, and AUROC 0.99.
Discussion
Our study demonstrates that ultrasound examination was
t h eb e s ts i n g l em e t h o df o rc o n f i r m i n gt h ed i a g n o s i so f
acute HF in the prehospital setting. Compared with clini-
cal assessment using modified Boston criteria and NT-
proBNP testing, lung ultrasound had a significantly better
AUROC with regard to diagnostic accuracy. Further-
more, the combination of ultrasound examination and
Table 3 Multiple logistic regression analysis of factors
used for differentiation between HF-related and
pulmonary-related acute dyspnea in prehospital
emergency setting
a
Factor OR (95% CI)
b P value
c
Ultrasound examination 53.7 (28.6 to 83.5) < 0.001
NT-proBNP 14.3 (8.1 to 29.4) < 0.001
Orthopnea 6.9 (1.9 to 18.39 < 0.001
Rales 5.1 (1.5 to 12.8) 0.014
Troponin T 2.1 (1.3 to 4.6) 0.018
petCO2 7.6 (2.9 to 19.6) < 0.001
HF medications 2.7 (1.3 to 5.1) 0.031
Asthma/COPD medications 0.12 (0.03 to 0.42) 0.028
Previous HF 7.4 (2.3 to 20.4) < 0.001
Fever 0.17 (0.06 to 0.49) 0.017
aOR, odds ratio; petCO2, partial pressure of end-tidal carbon dioxide; NT-
proBNP, amino terminal pro-brain natriuretic peptide; HF, heart failure; COPD,
chronic obstructive pulmonary disease; CI, confidence interval.
bUnivariable
screening was performed on clinical, historical and biochemical variables to
identify potential predictors of HF. Odds ratios for the presence of HF were
generated and expressed with 95% CI.
cMultivariable analysis with logistic
regression was used to identify potential predictor variables of a final
diagnosis of HF (variables from univariate analysis with P < 0.05 for entry into
model).
Table 4 Test characteristics of ultrasound examination, modified Boston examination, NT-proBNP and combination of
ultrasound examination and NT-proBNP
a
Characteristic Ultrasound
examination
b
Modified Boston criteria
scoring
NT-proBNP Ultrasound examination +
NT-proBNP
c
P value
d
Sensitivity 100%
(95% CI 98 to 100)
85%
(95% CI 79 to 89)
92%
(95% CI 88 to 95)
100%
(95% CI 98 to 100)
< 0.01
Specificity 95%
(95% CI 91 to 100)
86%
(95% CI 82 to 90)
89%
(95% CI 84 to 92)
100%
(95% CI 97 to 100)
< 0.01
NPV 100%
(95% CI 98 to 100)
80%
(95% CI 77 to 85)
86%
(95% CI 82 to 90)
100%
(95% CI 98 to 100)
< 0.01
PPV 96%
(95% CI 93 to 100)
90%
(95% CI 86 to 93)
90%
(95% CI 85 to 94)
100%
(95% CI 96 to 100)
< 0.01
LR
+ 20
(95% CI 1.98 to 89.94)
6.1
(95% CI 1.65 to 18.48)
8.36
(95% CI 1.72 to 33.86)
Infinite < 0.01
LR
- 0 0.18
(95% CI 0.07 to 0.52)
0.09
(95% CI 0.02 to 0.23)
0 < 0.01
AUROC 0.94
(95% CI: 0.90 to 0.97)
0.86
(95% CI 0.80 to 0.91)
0.90
(95% CI 0.84 to 0.94)
0.99
(95% CI 0.98 to 1.00)
< 0.01
aNPV, negative predictive value; PPV, positive predictive value; LR
+, positive likelihood ratio; LR
-, negative likelihood ratio; AUROC, area under receiver-operating
curve; NT-proBNP, amino terminal pro-brain natriuretic peptide; UE, ultrasound examination.
bUE alone was statistically significantly more accurate in diagnosing
HF than the modified Boston criteria and NT-proBNP (better sensitivity, specificity, NPV, PPV, LR
+,L R
- and AUROC; P < 0.01).
cThe combination of UE and NT-
proBNP was the supreme method in diagnosing HF in a prehospital setting; when compared with UE alone, it had equal results in sensitivity, NPV and LR
- (P =
0.99) and significantly better results in specificity, PPV and AUROC (P < 0.01). Compared with Boston modified criteria or NT-proBNP alone, UE + NT-proBNP was
significantly better with regard to all characteristics (sensitivity, specificity, NPV, PPV, LR
+,L R
- and AUROC; P < 0.01).
dThe comparison of the four methods was
done using the c
2 test with the Bonferroni correction for multiple comparisons. The AUROC accuracy of UE (lung comet-tail sign); NT-proBNP; Boston criteria for
diagnosing HF (clinical assessment); and the combination of ultrasound, NT-proBNP and Boston criteria were calculated and compared with univariate Z-score
testing. AUROC was compared using the technique proposed by Hanley and Mc Neil [20] and Jannuzzi et al. [21].
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more reliable method for the identification of acute HF
and its differentiation from COPD/asthma-related causes
of acute dyspnea.
Acute dyspnea is one of the most common condi-
tions encountered in emergency care settings. Correct
diagnosis and treatment are of primary importance, as
misdiagnosis can result in deleterious consequences for
patients. Timely differentiation of HF from other
causes of acute dyspnea (especially in cases of COPD/
asthma comorbidity) may be difficult. Physical exami-
nation, chest radiography, electrocardiography, and
standard biological tests often fail to accurately differ-
entiate HF from pulmonary causes of dyspnea [2,4-6].
Rapid NT-proBNP testing has been confirmed as a
highly sensitive and specific biomarker for the diagno-
sis or exclusion of acute HF in emergency care settings
[20,21] and may produce improvements in the prehos-
pital management of patients with dyspnea [7]. The
reliability of transthoracic lung ultrasound in differen-
tiating acute dyspnea has been confirmed in some pre-
vious studies by Lichtenstein et al. [9,10], Cardinale
et al. [8] and Volpicelli et al. [11]. The comet-tail sign
(B lines) has been proposed as a simple, non-time-con-
suming sonographic sign of pulmonary congestion and
can be obtained at bedside (also with portable echocar-
diographic equipment) [22]. Agricolla et al. [23] stu-
died the diagnostic accuracy of lung ultrasound in
diagnosing intersitial pulmonary edema and found sig-
nificant positive linear correlations between comet-tail
signs and chest radiography, wedge pressure and extra-
vascular lung water quantified by the indicator dilution
method. Liteplo et al. [12] reported that lung ultra-
sound could be used alone or could provide additional
predictive power to NT-proBNP in the immediate eva-
luation of dyspneic patients presenting to the emer-
gency department.
T h ed a t af r o mo u rs t u d y( s i m i l a r l yt ot h es t u d yb y
Liteplo et al. [12]) suggest that NT-proBNP and ultra-
sound examinations provide complementary diagnostic
information which may be useful in the early evaluation
of HF in the prehospital setting (that is, in the field).
The combination of these two methods has an excellent
statistical value: 100% sensitivity, specificity, NPV and
PPV; 99% AUROC; LR
+ infinite; and LR
- zero. To our
knowledge, no previous study has specifically compared
the utility of lung ultrasound and NT-proBNP in the
out-of-hospital setting, as researchers have focused on
the patients in emergency departments and intensive
care units. Zechner et al. [24] presented two cases of
dyspneic patients in whom prehospital lung ultrasound
helped to distinguish pulmonary edema from acute
exacerbation of COPD and suggested the application of
ultrasound in the field.
Prehospital emergency physicians offer the earliest
treatment of acute dyspnea, which is performed as soon
as clinically possible after the event. On the basis of
clinical judgment alone, it is sometimes very difficult to
distinguish cardiac from pulmonary causes of dyspnea.
If prehospital physicians have the tools of rapid NT-
proBNP testing and ultrasound at their disposal, the
diagnostic dilemmas in differentiating causes of dyspnea
are reduced and the treatment possibilities in clinically
obscure cases are mainly improved.
Ultrasound is currently the only imaging method that
can be used in the field. It offers an opportunity to
extend and improve out-of-hospital diagnostic possibili-
ties and is useful for prehospital emergency physicians
with additional knowledge of point-of-care ultrasound
diagnostics. Under special circumstances, it may be used
by well-educated paramedics [25,26]. The application of
the Bedside Lung Ultrasound in Emergency Protocol
[27] in the field presents an important moment of tran-
sition from in-hospital intensive care medicine to out-
of-hospital emergency medicine in the diagnostics and
treatment of acute dyspnea. In systems such as Slove-
nia’s, where there are medical doctors in prehospital set-
tings, this methodology could prevent transport and
hospitalization. In our next study, we intend to test the
efficacy of this methodology for preventing hospitaliza-
tion and improving cost and time efficiency by using
ultrasound in patients with dyspnea. On the basis of the
presented data, we have developed a simple algorithm
for using ultrasound in patients with dyspnea. If the
ultrasound does not show B lines, then the diagnosis is
COPD/asthma and further evaluation are unnecessary. If
there are B lines, then NT-pro-BNP should be mea-
sured. If NT-proBNP is positive, the diagnosis is acute
HF, and if NT-proBNP is negative, the diagnosis is
COPD/asthma. This algorithm could be a powerful tool
for emergency care providers, but further investigation
(a larger, multicenter study) is needed to validate the
utility of this algorithm in the prehospital setting.
This study has methodological limitations. In our ana-
lysis, we included only patients with primary HF or
COPD/asthma diagnosed in the field, and this limitation
decreases the generalizability of this study to other
causes of acute dyspnea in the prehospital setting. The
primary aim of our study was to determine the diagnos-
tic accuracy of bedside lung ultrasound and NT-proBNP
in differentiating HF-related acute dyspnea from COPD/
asthma-related acute dyspnea in prehospital settings.
Conclusions
Ultrasound examination of the lungs alone or in combi-
nation with NT-proBNP testing has high diagnostic
accuracy in differentiating acute HF-related from
COPD/asthma-related causes of acute dyspnea in
Prosen et al. Critical Care 2011, 15:R114
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Page 7 of 9prehospital emergency settings. The combination of
these two methods helps to improve the diagnostic and
treatment possibilities in clinically obscure cases of
acute dyspnea in the earliest phases of their appearance.
Both methods are simple, non-time-consuming and can
be used at bedside or in the field.
Key messages
￿ Diagnosis of severe, acute dyspnea in the prehospi-
tal arena and/or the emergency department can be
challenging, but lung ultrasound is proving to be an
accurate new diagnostic tool by itself or in combina-
tion with other diagnostic modalities.
￿ Pulmonary edema gives specific, diffusely vertical
artefact line (B lines and comet-tail signs) patterns
on ultrasound, unlike the results found in patients
with obstructive diseases or pulmonary emboli (gen-
erally A lines in both cases).
￿ The question remains how well specific patterns of
diffuse B lines on ultrasound scans correlate with
levels of NT-pro-BNP and how they help in making
the correct diagnosis.
￿ In our study, the combination of ultrasound exam-
ination and NT-proBNP had 100% sensitivity, 100%
specificity, 100% NPV and 100% PPV for differen-
tiating heart failure as the cause of acute dyspnea
compared to pulmonary causes in the prehospital
setting.
￿ Both ultrasound examinations and NT-pro-BNP
point-of-care assays are quick, accurate and feasible,
with high diagnostic accuracy, in the prehospital
arena.
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